Abbott’s dual ablation catheter lands FDA approval
The US Food and Drug Administration (FDA) has approved Abbott’s TactiFlex Duo, a dual ablation catheter indicated for the treatment …
Post
-
-
restor3d introduces MyFit digital suite for orthopaedic care
restor3d has launched MyFit by restor3d Digital Suite, a new platform intended to provide patients with improved visibility and engagement …
-
Labcorp acquires MLM Medical Labs to expand global central lab network
Labcorp has acquired MLM Medical Labs, expanding its worldwide central laboratory and biomarker capabilities for clinical studies. MLM is a central …
-
ERS 2026: AI lung imaging shows utility in detecting pulmonary fibrosis candidate’s efficacy
Brainomix’s AI-based quantitative lung imaging technology has been used to successfully detect therapeutic benefit in a clinical trial evaluating an …
-
OncoSil Medical secures funding for cancer device launch
Australian company OncoSil Medical, which develops targeted radiation therapies for difficult-to-treat cancers, has secured commitments for A$5.6m ($4.03m) in new …
-
OncoSil Medical secures funding for cancer device launch
Australian company OncoSil Medical, which develops targeted radiation therapies for difficult-to-treat cancers, has secured commitments for A$5.6m ($4.03m) in new …
-
Osaka has the science. Now it needs the business
Osaka has the science. Now it needs to build the companies, capital and global reach to turn that science into …
-
Boston Scientific on road to recovery following cyberattack
Following a cyberattack last month that rocked its operations, Boston Scientific has issued a positive update as it continues an …
-
Nyxoah implants first patient in BREATHE study of Genio
Belgium-based medical technology company Nyxoah has implanted the first patient in BREATHE, its US post-approval study of the Genio system …
-
Aptar Pharma to support Aceso’s inhaled cystic fibrosis candidate’s advance
Drug delivery specialist Aptar Pharma is collaborating with Aceso Therapeutics to advance development for the latter’s ACT-101 – an inhalable …
-
Remedying the paper trail: Manufacturing a digital route to compliance
Regulatory investigators’ remit extends beyond routine standard operating procedure (SOP) reviews; they watch how operators work, how equipment is qualified, …
-
Powerful Medical’s AI heart attack detection model secures FDA approval
The US Food and Drug Administration (FDA) has granted de novo authorisation to Powerful Medical’s Queen of Hearts, an AI …
-
Evinova and Lothar Medical partner on respiratory device trials
Evinova, a clinical development technology company within the AstraZeneca group, has agreed to a partnership with Lothar Medical to execute …
-
Philips launches eV14-2v transvaginal transducer
Philips has introduced the eV14-2v transvaginal transducer, an addition to its ultrasound range for obstetrics and gynaecology. The device has received …
-
Boston Scientific’s SCS leads linked to 1,081 serious injuries in FDA alert
The US Food and Drug Administration (FDA) has issued an alert over Boston Scientific’s recall of a lead kit used …
